Lipofectamine® 3000 Transfection Reagent leverages our most advanced lipid nanoparticle technology to provide superior transfection performance with improved application outcomes and reproducible results. This reagent delivers superior transfection efficiency and improved cell viability for the widest range of hard-to-transfect and common cells (e.g., HEK293, HeLa).
Successfully transfect the widest variety of biologically relevant cell types with a reagent that offers:
• Superior performance—our highest efficiency reagent for difficult-to-transfect cells
• Improved cell viability—gentle on your cells, with low toxicity
• Versatile—one reagent for DNA, RNA, and co-transfection
Efficiently Transfect Difficult-to-Transfect Cells
Lipofectamine® 3000 reagent is designed to efficiently transfect difficult-to-transfect cells, yielding superior transfection performance across the broadest array of cell types. Successfully transfected cell types include:
|Fibroblast (3T3, COS-7)||Myoblast (C2C12, L6 CRL-1458)|
|Hepatocyte (HepG2, HuH7)||Erythroleukemic cell (K562)|
|Breast carcinoma (MCF7, Hs578T)||Prostate carcinoma (LNCap)|
|Lung carcinoma (A549, NCI-H460)||Osteosarcoma (U-2 OS, Saos-2)|
|Colon carcinoma (Caco2, SW480)||Pancreatic carcinoma (PANC-1)|
|Skin melanoma (SK-MEL-28)|
Transfect Common Cells Efficiently and Cost-Effectively
For common cell types, Lipofectamine® 3000 reagent is more cost-effective than other reagents due to its high concentration and low usage amount. The 1.5 mL size provides up to 1500 transfection reactions (in 24-well plates).
Achieve Superior Transfection Efficiency While Maintaining Low Toxicity
Lipofectamine® 3000 reagent maintains a high transfection efficiency within a robust dynamic range of lipid doses for quick and easy optimization. A low toxicity lipid dose (0.75 µL for 24-well plates) is suggested for applications requiring minimal disruption of the cells.
Enable High Transfection Efficiency in Novel Genome Editing Applications
Lipofectamine® 3000 reagent is suitable for novel genome editing applications. It increases the likelihood of successful cleavage and recombination with TALENs or CRISPRs through highly efficient transfection, ultimately maximizing the efficiency of genetic modifications and simplifying the downstream processes.
|Cell Type:||Established Cell Lines, Hard-to-Transfect Cells, Primary Cells, Stem Cells|
|Sample Type (Specific):||Plasmid DNA, RNAi Plasmids (shRNA, miR), Synthetic siRNA|
|Transfection Technique:||Lipid-Based Transfection|
|Product Size:||1.5 mL|